Prime Highlights
- FPT launches MediSight as leading AI framework for global healthcare innovation.
- Framework combines AI agents with healthcare grade security and compliance standards.
Key Facts
- MediSight built on three core layers spanning data, AI agents and applications.
- FPT reported USD 2.66 billion revenue with over 54000 employees in 2025.
Background-
Global IT corporation FPT has launched MediSight, an AI-powered framework built to help healthcare providers, medical device manufacturers and pharmaceutical organisations speed up digital transformation, strengthen regulatory compliance and draw actionable insights from healthcare data.
The framework brings together autonomous AI digital workers, healthcare-specific applications and AI-augmented engineering capabilities to streamline clinical, operational and regulatory workflows, enabling faster, data-driven decisions across the healthcare value chain.
Built on FPT’s FleziPT AI-first ecosystem and guided by CASAN, the company’s framework for moving from AI experimentation to AI-native operations, MediSight allows healthcare and life sciences organisations to scale AI adoption across care delivery, business operations and compliance functions.
The framework runs on three core layers. The Healthcare Insight Platform offers a cloud-native, interoperable data foundation supporting standards such as HL7 v2, CDA, FHIR and DICOM, with built-in tools for data mapping, de-identification and clinical terminology standardisation.
MediSight Crew includes autonomous AI agents and healthcare-focused digital assistants that support administrative, clinical and compliance tasks. MediSight Verse provides a growing set of applications covering clinic management, claims administration, virtual care, patient engagement, clinical trials, medical imaging, documentation and healthcare analytics.
Built for healthcare-grade security, MediSight meets industry requirements including HIPAA, HITRUST r2 and ISO 27001, and can be deployed across major cloud environments while integrating with existing healthcare systems.
Chu Canh Chieu, FPT Software Vice President and Head of Healthcare and Life Sciences, said the next phase of healthcare innovation calls for systems that actively reason through data rather than simply storing it, and that MediSight helps organisations cut manual effort while improving decision-making speed.
The launch adds to FPT’s growing healthcare and life sciences portfolio, built on nearly two decades of experience serving healthcare providers, pharmaceutical companies and device manufacturers worldwide.
